<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01595373</url>
  </required_header>
  <id_info>
    <org_study_id>2012-28512</org_study_id>
    <nct_id>NCT01595373</nct_id>
  </id_info>
  <brief_title>Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue</brief_title>
  <official_title>Local Metabolic Effects of Ghrelin: A Clinical Microdialysis Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Esben Thyssen Vestergaard</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The metabolic effects of ghrelin is investigated by microdialysis technique. Subjects are
      healthy young men. End points are interstitial concentrations of glucose, lactate, and
      glycerol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interstitial concentrations of glycerol</measure>
    <time_frame>Interstitial concentrations of glycerol at t=120 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interstitial concentrations of lactate</measure>
    <time_frame>Interstitial concentrations of lactate at t=120 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interstitial concentrations of glucose</measure>
    <time_frame>Interstitial concentrations of glucose at t=120 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Ghrelin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ghrelin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ringer acetate is used for placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acyl ghrelin</intervention_name>
    <description>Acyl ghrelin 12.5 pg/min infused continuously for 300 minutes</description>
    <arm_group_label>Ghrelin</arm_group_label>
    <other_name>Human acyl ghrelin</other_name>
    <other_name>Ghrelin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (Ringer acetate)</intervention_name>
    <description>Ringer acetate 2 microliter/min for 300 minutes</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male

          -  age 18-65 years (included)

          -  Body mass index 20-25 (included)

        Exclusion Criteria:

          -  alcohol abuse

          -  malignant disease

          -  use of any medicine except otc painkillers

          -  any disease recognized

          -  participation in a trial using radioactive isotopes within the last 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esben T. Vestergaard, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2012</study_first_submitted>
  <study_first_submitted_qc>May 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2012</study_first_posted>
  <last_update_submitted>January 15, 2013</last_update_submitted>
  <last_update_submitted_qc>January 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Esben Thyssen Vestergaard</investigator_full_name>
    <investigator_title>Postdoc PhD</investigator_title>
  </responsible_party>
  <keyword>Ghrelin</keyword>
  <keyword>Microdialysis</keyword>
  <keyword>Controls</keyword>
  <keyword>Metabolic effects of ghrelin</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

